Maxim Group Initiates Coverage of Alterity Therapeutics Limited - Depositary Receipt with Buy Recommendation - MSN

ATHE Stock  USD 3.72  0.27  6.77%   
About 61% of Alterity Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Maxim Group Initiates Coverage of Alterity Therapeutics Limited - Depositary Receipt with Buy Recommendation MSN

Read at news.google.com
Google News at Macroaxis
  

Alterity Therapeutics Fundamental Analysis

We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Alterity Therapeutics is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Alterity Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.

Peers

Alterity Therapeutics Related Equities

MNPRMonopar Therapeutics   6.61   
0%
73.0%
RNAZTranscode Therapeutics   3.44   
0%
38.0%
NBYNovaBay Pharmaceuticals   3.13   
0%
34.0%
TARAProtara Therapeutics   2.22   
0%
24.0%
RVPHReviva Pharmaceuticals   1.52   
0%
16.0%
ANEBAnebulo Pharmaceuticals   1.23   
0%
13.0%
ARTLArtelo Biosciences   0.88   
0%
9.0%
ADILAdial Pharmaceuticals   0.93   
10.0%
0%
QNRXQuoin Pharmaceuticals   1.49   
16.0%
0%
PMVPPmv Pharmaceuticals   1.91   
21.0%
0%
ATXIAvenue Therapeutics   2.01   
22.0%
0%
ANTXAN2 Therapeutics   2.17   
24.0%
0%
ADTXAditxt   5.00   
55.0%
0%
HCWBHCW Biologics   6.82   
75.0%
0%
SRZNSurrozen   9.00   
100.0%
0%

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world